Eli Lilly Subsidiary Gets $3.9M In Fees Under Octane Ruling

Law360, Los Angeles (August 17, 2016, 8:47 PM EDT) -- A Pennsylvania federal judge Wednesday approved a special master’s recommendation of $3.9 million in fees to Eli Lilly and Co. subsidiary Avid Radiopharmaceuticals for its expenses defending a bad-faith patent suit by Alzheimer’s Institute of America Inc. deemed “exceptional” under the Octane Fitness decision.

The $3.9 million in fees approved by U.S. District Judge Timothy J. Savage is $2.9 million less than the total fees Avid, a private company borne out of research at the University of Pennsylvania to develop a brain-imaging agent for early signs...
To view the full article, register now.